Pharmabiz1h
BD expands capacity for advanced prefillable syringes and enhances injection experience for next generation of biologics
BD (Becton, Dickinson and Company), a leading global medical technology company, announced the commercial release of the BD ...
Pharmabiz1h
EMA’s human medicines committee elects Bruno Sepodes as new chair
EMA’s human medicines committee elects Bruno Sepodes as new chair: Amsterdam, The Netherlands Friday, September 20, 2024, ...
Pharmabiz2h
ME Therapeutics to begin testing of first mRNA formulations from NanoVation Therapeutics collaboration
ME Therapeutics to begin testing of first mRNA formulations from NanoVation Therapeutics collaboration: Vancouver, British Columbia Friday, September 20, 2024, 14:00 Hrs [IST] ME ...
Pharmabiz23h
SAKCON 2024 proves to be an event par excellence on patient centric care
In a landmark moment for the healthcare industry, the School of Business Management, NMIMS, Mumbai, in collaboration with ...
Pharmabiz4h
New Novartis data in relapsing MS reinforce benefits of Kesimpta for first-line and switch patients
New Novartis data in relapsing MS reinforce benefits of Kesimpta for first-line and switch patients: Basel Friday, September 20, 2024, 12:00 Hrs [IST] Novartis announced new data ...
Pharmabiz3h
Organon to buy Dermavant Sciences including its innovative dermatologic therapy, Vtama cream 1% to treat plaque psoriasis
Basel, Switzerland Friday, September 20, 2024, 13:00 Hrs [IST] ...
Pharmabiz3h
Neuberg Diagnostics launches personalized genomics platform, “Geniee-Decode your DNA”
Neuberg Diagnostics, a global leader in cutting-edge healthcare diagnostics, has officially launched its groundbreaking personalized genomics platform, “Geniee-Decode your DNA”. The launch signifies a ...
Pharmabiz6h
Takeda commits over US$ 32 million in five new global CSR partnerships to further drive health impact in 93 countries
Takeda commits over US$ 32 million in five new global CSR partnerships to further drive health impact in 93 countries: Osaka, Japan Friday, September 20, 2024, 10:00 Hrs [IST] Tak ...
Pharmabiz5h
Astellas Pharma announces US FDA listing of DIGITIVA for the management of heart failure
Astellas Pharma announces US FDA listing of DIGITIVA for the management of heart failure: Tokyo Friday, September 20, 2024, 11:00 Hrs [IST] Astellas Pharma Inc. announced that DIG ...
Pharmabiz7h
Roche announces phase III CENTERSTONE study of Xofluza significantly reduces the transmission of influenza viruses
Roche announces phase III CENTERSTONE study of Xofluza significantly reduces the transmission of influenza viruses: Basel Friday, September 20, 2024, 09:00 Hrs [IST] Roche announc ...
Pharmabiz8h
Karnataka DC dept launches online tracking system for sale of tapentadol as misuse reported
Karnataka DC dept launches online tracking system for sale of tapentadol as misuse reported: Nandita Vijaysimha, Bengaluru Friday, September 20, 2024, 08:00 Hrs [IST] The Karnatak ...
Pharmabiz8h
PvPI and ADR monitoring & reporting should be made part of pharmacy curriculum: Dr B Suresh
Peethaambaran Kunnathoor, Chennai Friday, September 20, 2024, 08:00 Hrs [IST] ...